Prognostic Factors for Renal Cell Carcinoma With Tumor Thrombus Extension

Journal of Urology

Volumn 178, Issue 4, 2007, Pages 1189-1195

  Klatte, Tobias ^a   Pantuck, Allan J ^a   Riggs, Stephen B ^a   Kleid, Mark D ^a   Shuch, Brian ^a   Zomorodian, Nazy ^a   Kabbinavar, Fairooz F ^a   Belldegrun, Arie S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

carcinoma; immunotherapy; kidney; prognosis; renal cell; thrombosis

Indexed keywords

ADULT; AGED; ANEMIA; ARTICLE; CANCER IMMUNOTHERAPY; CANCER INVASION; CANCER SURVIVAL; FEMALE; HEART ATRIUM; HUMAN; INFERIOR CAVA VEIN; KIDNEY CARCINOMA; KIDNEY VEIN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TUMOR CLASSIFICATION; TUMOR THROMBUS; WEIGHT REDUCTION;

AGED; CARCINOMA, RENAL CELL; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INTERFERON-ALPHA; INTERLEUKIN-2; KIDNEY; KIDNEY NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM CIRCULATING CELLS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 34548414116     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2007.05.134     Document Type: Article

References (20)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., and Thun M.J. Cancer statistics, 2007. CA Cancer J Clin 57 (2007) 43
2. Zisman A., Pantuck A.J., Chao D.H., Wieder J.A., Dorey F., Said J.W., et al. Renal cell carcinoma with tumor thrombus: is cytoreductive nephrectomy for advanced disease associated with an increased complication rate?. J Urol 168 (2002) 962
3. Nesbitt J.C., Soltero E.R., Dinney C.P., Walsh G.L., Schrump D.S., Swanson D.A., et al. Surgical management of renal cell carcinoma with inferior vena cava tumor thrombus. Ann Thorac Surg 63 (1997) 1592
4. Blute M.L., Leibovich B.C., Lohse C.M., Cheville J.C., and Zincke H. The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus. BJU Int 94 (2004) 33
5. Swierzewski D.J., Swierzewski M.J., and Libertino J.A. Radical nephrectomy in patients with renal cell carcinoma with venous, vena caval, and atrial extension. Am J Surg 168 (1994) 205
6. Naitoh J., Kaplan A., Dorey F., Figlin R., and Belldegrun A. Metastatic renal cell carcinoma with concurrent inferior vena caval invasion: long-term survival after combination therapy with radical nephrectomy, vena caval thrombectomy and postoperative immunotherapy. J Urol 162 (1999) 46
7. Zisman A., Wieder J.A., Pantuck A.J., Chao D.H., Dorey F., Said J.W., et al. Renal cell carcinoma with tumor thrombus extension: biology, role of nephrectomy and response to immunotherapy. J Urol 169 (2003) 909
8. Kavolius J.P., Mastorakos D.P., Pavlovich C., Russo P., Burt M.E., and Brady M.S. Resection of metastatic renal cell carcinoma. J Clin Oncol 16 (1998) 2261
9. Lam J.S., Leppert J.T., Belldegrun A.S., and Figlin R.A. Adjuvant therapy of renal cell carcinoma: patient selection and therapeutic options. BJU Int 96 (2005) 483
10. Skinner D.G., Pritchett T.R., Lieskovsky G., Boyd S.D., and Stiles Q.R. Vena caval involvement by renal cell carcinoma. Surgical resection provides meaningful long-term survival. Ann Surg 210 (1989) 387
11. Ficarra V., Novara G., Iafrate M., Cappellaro L., Bratti E., Zattoni F., et al. Proposal for reclassification of the TNM staging system in patients with locally advanced (pT3-4) renal cell carcinoma according to the cancer-related outcome. Eur Urol 51 (2007) 722
12. Leibovich B.C., Cheville J.C., Lohse C.M., Zincke H., Kwon E.D., Frank I., et al. Cancer specific survival for patients with pT3 renal cell carcinoma-can the 2002 primary tumor classification be improved?. J Urol 173 (2005) 716
13. Cummings K.B. Surgical management of renal cell carcinoma with extension into the vena cava. In: Crawford E.D., and Borden T.A. (Eds). Genitourinary Cancer Surgery (1982), Lea and Febiger, Philadelphia 70-85 chapt 8
14. Neves R.J., and Zincke H. Surgical treatment of renal cancer with vena cava extension. Br J Urol 59 (1987) 390
15. Hudes G., Carducci M., Tomczak P., Dutcher J., Figlin R.A., Kapoor A., et al. A phase 3, randomized, 3-arm study of temsirolimus (TEMSR) or interferon-alpha (IFN) or the combination of TEMSR + IFN in the treatment of first-line, poor-risk patients with advanced renal cell carcinoma (adv RCC). J Clin Oncol 24 (2006) LBA4
16. Figlin R.A. Renal cell carcinoma: management of advanced disease. J Urol 161 (1999) 381
17. Kim H.L., Zisman A., Han K.R., Figlin R.A., and Belldegrun A.S. Prognostic significance of venous thrombus in renal cell carcinoma. Are renal vein and inferior vena cava involvement different?. J Urol 171 (2004) 588
18. Ljungberg B., Stenling R., Österdahl B., Farrelly E., Åberg T., and Roos G. Vein invasion in renal cell carcinoma: impact on metastatic behavior and survival. J Urol 154 (1995) 1681
19. Skinner D.G., Lieskovsky G., and Pritchett T.R. Management of renal cell carcinoma involving the vena cava. In: Skinner D.G., and Lieskovsky G. (Eds). Diagnosis and Management of Genitourinary Cancer (1988), WB Saunders Co, Philadelphia 694-703 chapt 49
20. Staehler G., Liedl B., Kreuzer E., Sturm W., and Schmiedt E. Nierenkarzinom mit Cavazapfen: Einteilung, Operationsstrategie und Behandlungsergebnisse. Urologe A 26 (1987) 46